REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB

被引：0
|
作者：
Raluy-Callado, Mireia
Carroll, Robert
Curtis, Rebecca
Khalid, Javaria Mona
Patel, Haridarshan
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 01期
关键词：
D O I：
10.1053/j.gastro.2017.11.249
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P190
引用
收藏
页码：S105 / S106
页数：2
相关论文
共 50 条
  • [31] PATTERNS OF STEROID USE AMONG A REAL-WORLD NATIONAL COHORT OF VETERANS WITH INFLAMMATORY BOWEL DISEASE
    Pham, Codey
    Xu, Anthony
    Sansgiry, Shubhada
    Waljee, Akbar
    Hou, Jason
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S79 - S79
  • [32] PATTERNS OF STEROID USE AMONG A REAL-WORLD NATIONAL COHORT OF VETERANS WITH INFLAMMATORY BOWEL DISEASE
    Pham, Codey
    Xu, Anthony
    Sansgiry, Shubhada
    Waljee, Akbar
    Hou, Jason
    GASTROENTEROLOGY, 2023, 164 (04) : S101 - S102
  • [33] SAFETY OF VEDOLIZUMAB USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Shivashankar, Raina
    Ladd, Antonio H. Mendoza
    Grace, Rory
    Aberra, Faten
    Lichtenstein, Gary R.
    GASTROENTEROLOGY, 2017, 152 (05) : S585 - S585
  • [34] REAL-WORLD TRENDS IN CLINICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS INITIATING VEDOLIZUMAB OVER TIME IN ISRAEL
    Weil, C.
    Chodick, G.
    Shalev, V
    Demuth, D.
    Petrakis, I
    Ben Baruch, O.
    Tsukinovsky, S.
    Yarden, A.
    VALUE IN HEALTH, 2018, 21 : S142 - S142
  • [35] COMPARISON OF REAL-WORLD TREATMENT OUTCOMES WITH INFLIXIMAB VERSUS VEDOLIZUMAB IN BIOLOGIC-NAIVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Latremouille-Viau, Dominick
    Burne, Rebecca
    Shi, Sherry
    Adsul, Shashi
    Patel, Haridarshan
    GASTROENTEROLOGY, 2019, 156 (06) : S638 - S639
  • [36] Vedolizumab Use in Pediatric Patients With Inflammatory Bowel Disease
    Singh, Namita
    Patel, Minesh
    Rabizadeh, Shervin
    Dubinsky, Marla
    GASTROENTEROLOGY, 2015, 148 (04) : S72 - S72
  • [37] Comparison of Real-World Treatment Outcomes With Vedolizumab Versus Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease
    Patel, Haridarshan
    Latremouille-Viau, Dominick
    Burne, Rebecca
    Shi, Sherry
    Adsul, Shashi
    CROHNS & COLITIS 360, 2019, 1 (02)
  • [38] Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab
    Yamada, Akihiro
    Komaki, Yuga
    Patel, Nayan
    Komaki, Fukiko
    Aelvoet, Arthur S.
    Tran, Anthony L.
    Pekow, Joel
    Dalal, Sushila
    Cohen, Russell D.
    Cannon, Lisa
    Umanskiy, Konstantin
    Smith, Radhika
    Hurst, Roger
    Hyman, Neil
    Rubin, David T.
    Sakuraba, Atsushi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (09): : 1423 - 1429
  • [39] Articular Manifestations in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    Dupre, Anastasia
    Collins, Michael
    Carbonnel, Franck
    Mariette, Xavier
    Seror, Raphaele
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [40] The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases
    Macaluso, Fabio Salvatore
    Orlando, Rosalba
    Fries, Walter
    Scolaro, Mariangela
    Magnano, Antonio
    Pluchino, Dario
    Cappello, Maria
    Morreale, Gaetano Cristian
    Siringo, Sebastiano
    Privitera, Antonino Carlo
    Ferracane, Concetta
    Belluardo, Nunzio
    Alberghina, Nadia
    Ventimiglia, Marco
    Rizzuto, Giulia
    Renna, Sara
    Cottone, Mario
    Orlando, Ambrogio
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (07) : 675 - 681
12345